Efficacy and safety of EGFR-TKIs in combination with angiogenesis inhibitors as first-line therapy for advanced EGFR-mutant non-small-cell lung cancer: a systematic review and meta...

por Hu, Di, Zhou, Yan-Yan, Ma, Hong-Bo, Tao, Miao-Miao, Huang, Qun-Zhen, Yang, Zhen-Zhou, Zhou, Qi
Publicado 2023